<!DOCTYPE html>
<html
  lang="en-GB"
  xmlns:og="https://ogp.me/ns#"
  xmlns:fb="https://ogp.me/ns/fb#"
>
  <head>
    <meta charset="UTF-8" />
    <title>
      COMPare - Post-hoc “pre-specification” and undeclared deferral of results:
      a broken record in the making
    </title>
    <meta name="robots" content="noodp,noydir" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <link rel="dns-prefetch" href="https://w.sharethis.com/" />

    <link
      rel="alternate"
      type="application/rss+xml"
      title="COMPare &raquo; Feed"
      href="../../feed/index.html"
    />
    <link
      rel="alternate"
      type="application/rss+xml"
      title="COMPare &raquo; Comments Feed"
      href="../../comments/feed/index.html"
    />
    <link
      rel="alternate"
      type="application/rss+xml"
      title="COMPare &raquo; Post-hoc “pre-specification” and undeclared deferral of results: a broken record in the making Comments Feed"
      href="feed/index.html"
    />
    <link rel="canonical" href="index.html" />
    <link
      rel="stylesheet"
      id="parallax-pro-theme-css"
      href="../../wp-content/themes/parallax-pro/style.css"
      type="text/css"
      media="all"
    />
    <link
      rel="stylesheet"
      id="sm-style-css"
      href="../../wp-content/plugins/wp-show-more/wpsm-style.css"
      type="text/css"
      media="all"
    />
    <link
      rel="stylesheet"
      id="kamn-css-easy-twitter-feed-widget-css"
      href="../../wp-content/plugins/easy-twitter-feed-widget/easy-twitter-feed-widget.css"
      type="text/css"
      media="all"
    />
    <link
      rel="stylesheet"
      id="dashicons-css"
      href="../../wp-includes/css/dashicons.min.css"
      type="text/css"
      media="all"
    />
    <link rel="preconnect" href="https://fonts.gstatic.com" />
    <link
      href="https://fonts.googleapis.com/css2?family=Montserrat&family=Sorts+Mill+Goudy&display=swap"
      rel="stylesheet"
    />
    <link
      rel="stylesheet"
      id="sccss_style-css"
      href="../../index.css"
      type="text/css"
      media="all"
    />
    <script
      type="text/javascript"
      src="../../wp-includes/js/jquery/jquery.js"
    ></script>
    <script
      type="text/javascript"
      src="../../wp-includes/js/jquery/jquery-migrate.min.js"
    ></script>
    <script type="text/javascript">
      /* <![CDATA[ */
      var cssTarget = "img.";
      /* ]]> */
    </script>
    <script
      type="text/javascript"
      src="../../wp-content/plugins/svg-support/js/min/svg-inline-min.js"
    ></script>
    <!--[if lt IE 9]>
      <script
        type="text/javascript"
        src="https://www.compare-trials.org/wp-content/themes/genesis/lib/js/html5shiv.min.js?ver=3.7.3"
      ></script>
    <![endif]-->
    <script
      type="text/javascript"
      src="../../wp-content/themes/parallax-pro/js/responsive-menu.js"
    ></script>
    <script
      id="st_insights_js"
      type="text/javascript"
      src="https://w.sharethis.com/button/st_insights.js?publisher=eba0f3ba-f9ab-408c-bc68-c28af5afe749&#038;product=feather"
    ></script>
    <link rel="https://api.w.org/" href="../../wp-json/index.html" />
    <link
      rel="EditURI"
      type="application/rsd+xml"
      title="RSD"
      href="../../xmlrpc.php%3Frsd"
    />
    <link
      rel="alternate"
      type="application/json+oembed"
      href="../../wp-json/oembed/1.0/embed%3Furl=http:%252F%252Fcompare-trials.org%252Fblog%252Fpost-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making%252F"
    />
    <link
      rel="alternate"
      type="text/xml+oembed"
      href="../../wp-json/oembed/1.0/embed%3Furl=http:%252F%252Fcompare-trials.org%252Fblog%252Fpost-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making%252F&amp;format=xml"
    />
    <style type="text/css"></style>

    <style type="text/css"></style>

    <style type="text/css">
      .synved-social-resolution-single {
        display: inline-block;
      }
      .synved-social-resolution-normal {
        display: inline-block;
      }
      .synved-social-resolution-hidef {
        display: none;
      }

      @media only screen and (min--moz-device-pixel-ratio: 2),
        only screen and (-o-min-device-pixel-ratio: 2/1),
        only screen and (-webkit-min-device-pixel-ratio: 2),
        only screen and (min-device-pixel-ratio: 2),
        only screen and (min-resolution: 2dppx),
        only screen and (min-resolution: 192dpi) {
        .synved-social-resolution-normal {
          display: none;
        }
        .synved-social-resolution-hidef {
          display: inline-block;
        }
      }
    </style>
    <link
      rel="icon"
      href="../../wp-content/uploads/2016/01/cropped-original-32x32.png"
      sizes="32x32"
    />
    <link
      rel="icon"
      href="../../wp-content/uploads/2016/01/cropped-original-192x192.png"
      sizes="192x192"
    />
    <link
      rel="apple-touch-icon-precomposed"
      href="../../wp-content/uploads/2016/01/cropped-original-180x180.png"
    />
    <meta
      name="msapplication-TileImage"
      content="https://www.compare-trials.org/wp-content/uploads/2016/01/cropped-original-270x270.png"
    />

    <script
      id="plausible"
      defer
      data-domain="compare-trials.org"
      src="https://plausible.io/js/plausible.compat.js"
    ></script>

    <!-- START - Facebook Open Graph, Google+ and Twitter Card Tags 2.0.4 -->
    <!-- Facebook Open Graph -->
    <meta property="og:locale" content="en_GB" />
    <meta property="og:site_name" content="COMPare" />
    <meta
      property="og:title"
      content="Post-hoc “pre-specification” and undeclared deferral of results: a broken record in the making"
    />
    <meta
      property="og:url"
      content="https://www.compare-trials.org/blog/post-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making/"
    />
    <meta property="og:type" content="article" />
    <meta
      property="og:description"
      content="COMPare aims to fix the prevalent and ongoing problem of outcome switching in clinical trials. In short, outcome switching is when trialists report something different to what they originally said they were going to: it increases the risk of false positive results and exaggerated findings, and is th"
    />
    <meta
      property="og:image"
      content="https://www.compare-trials.org/wp-content/uploads/2016/01/logo_large-1.png"
    />
    <meta
      property="article:published_time"
      content="2016-01-29T15:28:19+00:00"
    />
    <meta
      property="article:modified_time"
      content="2016-03-30T16:40:34+00:00"
    />
    <meta property="og:updated_time" content="2016-03-30T16:40:34+00:00" />
    <meta property="article:section" content="Uncategorized" />
    <!-- Google+ / Schema.org -->
    <meta
      itemprop="name"
      content="Post-hoc “pre-specification” and undeclared deferral of results: a broken record in the making"
    />
    <meta
      itemprop="description"
      content="COMPare aims to fix the prevalent and ongoing problem of outcome switching in clinical trials. In short, outcome switching is when trialists report something different to what they originally said they were going to: it increases the risk of false positive results and exaggerated findings, and is th"
    />
    <meta
      itemprop="image"
      content="https://www.compare-trials.org/wp-content/uploads/2016/01/logo_large-1.png"
    />
    <!-- Twitter Cards -->
    <meta
      name="twitter:title"
      content="Post-hoc “pre-specification” and undeclared deferral of results: a broken record in the making"
    />
    <meta
      name="twitter:url"
      content="https://www.compare-trials.org/blog/post-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making/"
    />
    <meta
      name="twitter:description"
      content="COMPare aims to fix the prevalent and ongoing problem of outcome switching in clinical trials. In short, outcome switching is when trialists report something different to what they originally said they were going to: it increases the risk of false positive results and exaggerated findings, and is th"
    />
    <meta
      name="twitter:image"
      content="https://www.compare-trials.org/wp-content/uploads/2016/01/logo_large-1.png"
    />
    <meta name="twitter:card" content="summary" />
    <meta name="twitter:site" content="@compare_trials" />
    <!-- SEO -->
    <meta
      name="description"
      content="COMPare aims to fix the prevalent and ongoing problem of outcome switching in clinical trials. In short, outcome switching is when trialists report something different to what they originally said they were going to: it increases the risk of false positive results and exaggerated findings, and is th"
    />
    <!-- Misc. tags -->
    <!-- END - Facebook Open Graph, Google+ and Twitter Card Tags 2.0.4 -->
  </head>
  <body
    class="single single-post postid-268 single-format-standard full-width-content"
    itemscope
    itemtype="https://schema.org/WebPage"
  >
    <aside class="paper-alert" role="alert">
      <p>Read the COMPare papers:</p>
      <ul>
        <li><a href="https://doi.org/10.1186/s13063-019-3173-2">A prospective cohort study correcting and monitoring 58 misreported trials in real time</a></li>
        <li><a href="https://doi.org/10.1186/s13063-019-3172-3">Qualitative analysis of researchers’ responses to critical correspondence on a cohort of 58 misreported trials</a></li>
      </ul>
    </aside>
    <div class="site-container">
      <header
        class="site-header"
        itemscope
        itemtype="https://schema.org/WPHeader"
      >
        <div class="wrap">
          <div class="title-area">
            <h1 class="site-title" itemprop="headline">
              <a href="../../index.html">COMPare</a>
            </h1>
            <h2 class="site-description" itemprop="description">
              Tracking switched outcomes in clinical trials
            </h2>
          </div>
          <div class="widget-area header-widget-area">
            <section id="nav_menu-3" class="widget widget_nav_menu">
              <div class="widget-wrap">
                <nav
                  class="nav-header"
                  itemscope
                  itemtype="https://schema.org/SiteNavigationElement"
                >
                  <ul id="menu-main-menu" class="menu genesis-nav-menu">
                    <li
                      id="menu-item-14"
                      class="menu-item menu-item-type-post_type menu-item-object-page menu-item-14"
                    >
                      <a href="../../project.html" itemprop="url"
                        ><span itemprop="name">Methods</span></a
                      >
                    </li>
                    <li
                      id="menu-item-15"
                      class="menu-item menu-item-type-post_type menu-item-object-page menu-item-15"
                    >
                      <a href="../../results.html" itemprop="url"
                        ><span itemprop="name">Results</span></a
                      >
                    </li>
                    <li
                      id="menu-item-13"
                      class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-13"
                    >
                      <a href="../../team.html" itemprop="url"
                        ><span itemprop="name">Team</span></a
                      >
                      <ul class="sub-menu">
                        <li
                          id="menu-item-633"
                          class="menu-item menu-item-type-post_type menu-item-object-page menu-item-633"
                        >
                          <a href="../../speaking.html" itemprop="url"
                            ><span itemprop="name">SPEAKING DATES</span></a
                          >
                        </li>
                      </ul>
                    </li>
                    <li
                      id="menu-item-230"
                      class="menu-item menu-item-type-post_type menu-item-object-page menu-item-230"
                    >
                      <a href="../../faq.html" itemprop="url"
                        ><span itemprop="name">FAQ</span></a
                      >
                    </li>
                    <li
                      id="menu-item-19"
                      class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-19"
                    >
                      <a href="../index.html" itemprop="url"
                        ><span itemprop="name">Blog</span></a
                      >
                    </li>
                  </ul>
                </nav>
              </div>
            </section>
          </div>
        </div>
      </header>
      <div class="site-inner">
        <div class="content-sidebar-wrap">
          <main class="content">
            <article
              class="post-268 post type-post status-publish format-standard category-uncategorized tag-annals entry"
              itemscope
              itemtype="https://schema.org/CreativeWork"
            >
              <header class="entry-header">
                <h1 class="entry-title" itemprop="headline">
                  Post-hoc “pre-specification” and undeclared deferral of
                  results: a broken record in the making
                </h1>
                <p class="entry-meta">
                  <time
                    class="entry-time"
                    itemprop="datePublished"
                    datetime="2016-01-29T15:28:19+00:00"
                    >January 29, 2016</time
                  >
                  - by
                  <span
                    class="entry-author"
                    itemprop="author"
                    itemscope
                    itemtype="https://schema.org/Person"
                    ><a
                      href="../author/henrydrysdale/index.html"
                      class="entry-author-link"
                      itemprop="url"
                      rel="author"
                      ><span class="entry-author-name" itemprop="name"
                        >Henry Drysdale</span
                      ></a
                    ></span
                  >
                  <span class="entry-comments-link"
                    ><a href="index.html#comments">1 Comment</a></span
                  >
                </p>
              </header>
              <div class="entry-content" itemprop="text">
                <h4>
                  <span style="font-weight: 400; color: #000000"
                    >COMPare aims to fix the prevalent and ongoing problem of
                    outcome switching in clinical trials. In short, outcome
                    switching is when trialists report something different to
                    what they originally said they were going to: it increases
                    the risk of false positive results and exaggerated findings,
                    and is therefore a bad thing.
                  </span>
                </h4>
                <p>
                  <span style="font-weight: 400"
                    ><span style="color: #000000"
                      >For 6 weeks we assessed every trial published in the top
                      5 medical journals for discrepancies between pre-specified
                      and reported outcomes. Of 67 trials, we found that 58
                      (87%) contain</span
                    > </span
                  ><a href="../../results.html"
                    ><span style="font-weight: 400"
                      >misreported outcomes</span
                    ></a
                  ><span style="font-weight: 400; color: #000000"> [1]. </span>
                </p>
                <p>
                  <span style="font-weight: 400"
                    ><span style="color: #000000"
                      >That was phase 1 of COMPare. We are now in phase 2:
                      blogging on our findings and engaging the journals and
                      authors in </span
                    >public<span style="color: #000000">
                      discussion on our specific assessments and their attitudes
                      and policies on outcome reporting. The range of responses
                      this has generated has been fascinating and enlightening;
                      from</span
                    > </span
                  ><a
                    href="../reeact-in-the-bmj-good-science-in-action/index.html"
                    ><span style="font-weight: 400"
                      >best practice demonstrated by the BMJ
                    </span></a
                  ><span style="font-weight: 400"
                    ><span style="color: #000000"
                      >[2], to extremely</span
                    > </span
                  ><a
                    href="../where-does-annals-of-internal-medicine-stand-on-outcome-switching-a-detailed-response/index.html"
                    ><span style="font-weight: 400">concerning views</span></a
                  ><span style="font-weight: 400; color: #000000">
                    expressed and actions taken by Annals of Internal Medicine
                    [3]. We are beginning to see a set of recurring themes in
                    these responses that shed light on the underlying reasons
                    for this prevalent problem; largely based on a fundamental
                    misunderstanding of the importance of pre-specification and
                    correct reporting of outcomes.</span
                  >
                </p>
                <p><span id="more-268"></span></p>
                <p>
                  <span style="font-weight: 400"
                    ><span style="color: #000000"
                      >Responses from the authors and Annals’ editors on our
                      analysis of the</span
                    > </span
                  ><a href="https://annals.org/article.aspx?articleid=2467961"
                    ><span style="font-weight: 400">ATLAS trial</span></a
                  ><span style="font-weight: 400"
                    ><span style="color: #000000">
                      are a great example of the problems we have uncovered. We
                      assessed this trial back in November, found a range of
                      problems in the reporting of its outcomes, and
                      submitted</span
                    > </span
                  ><a
                    href="https://docs.google.com/document/d/1M_KNDBeSh4WVvWyz4nobpon4-LYGNNOlG-dXChChUTo/edit"
                    ><span style="font-weight: 400">a letter</span></a
                  ><span style="font-weight: 400; color: #000000">
                    to Annals to correct the record. You can see our full
                    analysis </span
                  ><a
                    href="https://docs.google.com/spreadsheets/d/1qVmaNwxclrTtZzUh2YaecFj7bOIAIndvRSoRkHyQMBQ/edit"
                    ><span style="font-weight: 400">here</span></a
                  ><span style="font-weight: 400"
                    >,<span style="color: #000000">
                      but in summary: the primary outcome was only reported for
                      1 of the 3 pre-specified </span
                    >time-points<span style="color: #000000"
                      >, only 6 of 17 pre-specified secondary outcomes were
                      reported, and lots of new analyses were reported without
                      being declared as non-prespecified. If you’re still unsure
                      about why this is bad, read</span
                    > </span
                  ><a href="https://www.COMPare-trials.org"
                    ><span style="font-weight: 400">our website</span></a
                  ><span style="font-weight: 400"
                    >,<span style="color: #000000"> our</span> </span
                  ><a href="../../wp-content/uploads/2016/01/protocol.pdf"
                    ><span style="font-weight: 400">protocol</span></a
                  ><span style="font-weight: 400; color: #000000"
                    >, and this </span
                  ><a href="https://xkcd.com/882/"
                    ><span style="font-weight: 400">great xkcd cartoon</span></a
                  ><span style="font-weight: 400">. </span>
                </p>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >Following our letter on the Annals website, the lead author
                    of ATLAS, Dr Hugh MacPherson, posted </span
                  ><a href="https://annals.org/article.aspx?articleid=2467961"
                    ><span style="font-weight: 400">a response</span></a
                  ><span style="font-weight: 400; color: #000000"
                    >, in which he demonstrates a number of misunderstandings of
                    the problem and our methods:
                  </span>
                </p>
                <blockquote>
                  <p>
                    <span style="font-weight: 400; color: #000000"
                      >When we registered our primary outcome measure, the
                      Northwick Park Neck Pain Questionnaire, we specified that
                      it would be ‘measured at baseline, 3, 6 and 12 months’.
                      The authors of the Comment incorrectly stated that there
                      were ‘3 pre-specified primary outcomes (one score at 3
                      timepoints)’</span
                    >
                  </p>
                  <p>
                    <span style="font-weight: 400; color: #000000"
                      >The Registry entry does not ask for a primary
                      end-point.</span
                    >
                  </p>
                </blockquote>
                <p>
                  <span style="font-weight: 400"
                    ><span style="color: #000000">In the</span> </span
                  ><a
                    href="https://www.consort-statement.org/checklists/view/32-consort/80-outcomes"
                    ><span style="font-weight: 400">CONSORT guidelines</span></a
                  ><span style="color: #000000"
                    ><span style="font-weight: 400">
                      [4], an adequate specification of an outcome </span
                    ><i
                      ><span style="font-weight: 400"
                        >includes the time-point</span
                      ></i
                    ><span style="font-weight: 400">; so, if you have </span
                    ><i
                      ><span style="font-weight: 400"
                        >3 different time-points</span
                      ></i
                    ><span style="font-weight: 400">, this</span
                    ><i
                      ><span style="font-weight: 400">
                        is 3 different outcomes</span
                      ></i
                    ><span style="font-weight: 400">. The registry entry </span
                    ><i><span style="font-weight: 400">does</span></i
                    ><span style="font-weight: 400">
                      ask for a primary “end-point” (time-point), simply by
                      asking for the primary outcome.
                    </span></span
                  >
                </p>
                <p>
                  <span style="color: #000000"
                    ><span style="font-weight: 400"
                      >The distinction between “end-points” and “time-points” is
                      not one that we recognise as widely accepted or used: a
                      trial’s registry entry </span
                    ><i><span style="font-weight: 400">must</span></i
                    ><span style="font-weight: 400">
                      contain a time-point for each outcome in order for those
                      outcomes to be adequately defined. We are aware of no
                      tradition of pre-specifying three time points, but
                      silently nominating one as the most important, without
                      noting or registering this anywhere. We would be
                      interested to hear from any researcher who disagrees.
                    </span></span
                  >
                </p>
                <blockquote>
                  <p>
                    <span style="font-weight: 400; color: #000000"
                      >In our protocol, published 2 years before the main trial
                      results, we specified that the 12 months outcome on this
                      questionnaire was our primary outcome end-point. Hence,
                      the 12 month end-point was the one we reported as the
                      primary end-point in our published paper. It is important
                      that the primary outcome is identified in advance of
                      analysis of the main trial results to avoid ‘cherry
                      picking’ trial outcomes: and this is what we did.</span
                    >
                  </p>
                </blockquote>
                <p>
                  <span style="color: #000000"
                    ><span style="font-weight: 400"
                      >To reduce the risk of selective outcome reporting and
                      false positive results, all primary and secondary outcomes
                      must be specified </span
                    ><i
                      ><span style="font-weight: 400"
                        >before trial commencement</span
                      ></i
                    ></span
                  ><span style="font-weight: 400"
                    ><span style="color: #000000"
                      >, as stated in the</span
                    > </span
                  ><a
                    href="https://www.consort-statement.org/checklists/view/32-consort/80-outcomes"
                    ><span style="font-weight: 400">CONSORT guidelines</span></a
                  ><span style="color: #000000"
                    ><span style="font-weight: 400">
                      [4]. Dr MacPherson is mistaken here in thinking that
                      pre-specification “in advance of analysis of the main
                      trial results” is sufficient. The protocol cited in Dr
                      MacPherson’s comment [5] was published </span
                    ><i
                      ><span style="font-weight: 400"
                        >over a year after trial commencement</span
                      ></i
                    ><span style="font-weight: 400">
                      and therefore cannot, by definition, contain </span
                    ><i><span style="font-weight: 400">pre-specified</span></i
                    ><span style="font-weight: 400"> outcomes. </span></span
                  >
                </p>
                <blockquote>
                  <p>
                    <span style="font-weight: 400; color: #000000"
                      >Of the 17 secondary pre-specified outcome measures, all
                      of them have been or will be reported in the primary paper
                      or in secondary papers that are currently being prepared.
                      These papers will report on the as yet unpublished
                      outcomes that are part of our pre-specified mediator-based
                      analyses that have been described in detail in our
                      published protocol.</span
                    >
                  </p>
                </blockquote>
                <p>
                  <span style="font-weight: 400"
                    ><span style="color: #000000"
                      >Here Dr MacPherson argues it is acceptable for 11 of the
                      17 pre-specified secondary outcomes to be left unreported
                      because they will be reported in a subsequent publication,
                      and we absolutely agree. However,</span
                    > </span
                  ><a
                    href="https://www.consort-statement.org/checklists/view/32-consort/81-changes-to-outcomes"
                    ><span style="font-weight: 400">as CONSORT states</span></a
                  ><span style="color: #000000"
                    ><span style="font-weight: 400">, this deferral </span
                    ><i
                      ><span style="font-weight: 400"
                        >must be declared in the trial publication</span
                      ></i
                    ><span style="font-weight: 400"
                      >. This is so that readers know that the reported outcomes
                      represent only a subset of those pre-specified, and that
                      those remaining will be reported elsewhere. It seems Dr
                      MacPherson and Annals’ editors share this view, because
                      the
                    </span></span
                  ><a href="https://annals.org/article.aspx?articleid=2467961"
                    ><span style="font-weight: 400">ATLAS publication</span></a
                  ><span style="font-weight: 400; color: #000000">
                    [6] states:
                  </span>
                </p>
                <blockquote>
                  <p>
                    <span style="font-weight: 400; color: #000000"
                      >Dr. MacPherson (the manuscript&#8217;s guarantor) affirms
                      that &#8230; any discrepancies from the study as planned
                      (and, if relevant, registered) have been explained.</span
                    >
                  </p>
                </blockquote>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >As we have shown, from comparing the publicly available
                    registry entry and Annals publication, this was not done in
                    the ATLAS trial report, and these discrepancies went
                    unexplained. To reiterate: Dr MacPherson agrees, in his
                    response to our Annals letter, that there are discrepancies
                    from the study as planned which were not explained in the
                    publication; but guarantees in the statement above that all
                    such discrepancies have been explained. He lastly
                    argues:</span
                  >
                </p>
                <blockquote>
                  <p>
                    <span style="font-weight: 400; color: #000000"
                      >While we support the CONSORT guidelines on best practice
                      in trial reporting, we are concerned about the ambiguity
                      of Registry entry labelling and scope for
                      misinterpretation either by researchers when entering data
                      at the outset of a trial, or by commentators, as is the
                      case we discuss here.</span
                    >
                  </p>
                </blockquote>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >This is a deeply worrying view of trial registries. Their
                    purpose is to prospectively define, in the public domain,
                    key information on each clinical trial, including its
                    pre-specified outcomes. Trialists and journal editors are
                    responsible for ensuring that information in trial
                    registries and protocols is not “ambiguous”. Where outcomes
                    are poorly prespecified, results could be selected post-hoc
                    from a range of possibilities: this potentiates selective
                    reporting of outcomes, and allows serious distortions in the
                    evidence presented.
                  </span>
                </p>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >We responded in full to the Editors’ response in a
                    previous</span
                  ><a
                    href="../where-does-annals-of-internal-medicine-stand-on-outcome-switching-a-detailed-response/index.html"
                  >
                    <span style="font-weight: 400">blog post</span></a
                  ><span style="font-weight: 400; color: #000000"
                    >; our submitted online comment was rejected on the basis of
                    a 400 word limit, although the</span
                  ><a href="https://annals.org/article.aspx?articleid=2478526">
                    <span style="font-weight: 400"
                      >letter from Annals’ editors</span
                    ></a
                  ><span style="font-weight: 400; color: #000000">
                    to which we were responding was 850 words long. In addition,
                    Annals have said they will not publish our responses in the
                    journal, although they have published their own 850 word
                    letter in full, in the print edition.</span
                  >
                </p>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >We think this is unfortunate. The misunderstandings
                    expressed by authors and Annals editors described above help
                    explain why outcome switching continues to be so prevalent
                    in leading journals, despite claims by editors that they
                    endorse best practice. These issues are vitally important to
                    the accurate reporting of trial results and can only be
                    resolved through clear public discussion.</span
                  >
                </p>
                <p>
                  <span style="color: #000000"
                    ><b style="line-height: 1.5"
                      >Henry Drysdale, Ben Goldacre, Carl Heneghan, on behalf of
                      the COMPare team </b
                    ><span style="font-weight: 400"> </span
                  ></span>
                </p>
                <p>&nbsp;</p>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >References:</span
                  >
                </p>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >[1] The CEBM Outcome Monitoring Project, </span
                  ><a href="https://www.COMPare-trials.org"
                    ><span style="font-weight: 400"
                      >www.COMPare-trials.org</span
                    ></a
                  ><span style="font-weight: 400; color: #000000"
                    >, last accessed 29/01/2016</span
                  >
                </p>
                <p>
                  <span style="color: #000000"
                    ><span style="font-weight: 400">[2] </span
                    ><span style="font-weight: 400"
                      >Correction on the REEACT trial, published 12/01/2016:
                    </span></span
                  ><a href="https://www.bmj.com/content/352/bmj.i195"
                    ><span style="font-weight: 400"
                      >https://www.bmj.com/content/352/bmj.i195</span
                    ></a
                  ><span style="font-weight: 400"
                    >, <span style="color: #000000">las</span></span
                  ><span style="font-weight: 400; color: #000000"
                    >t accessed 20/01/2016.</span
                  >
                </p>
                <p>
                  <span style="color: #000000"
                    ><span style="font-weight: 400"
                      >[3] Annals Editors, Discrepancies Between Prespecified
                      and Reported Outcomes, </span
                    ><i
                      ><span style="font-weight: 400">Ann Intern Med. </span></i
                    ><span style="font-weight: 400"
                      >Published online 22 December 2015</span
                    ></span
                  >
                </p>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >[4] Moher D et al, CONSORT 2010 Explanation and
                    Elaboration: updated guidelines for reporting parallel group
                    randomised trials, BMJ 2010; 340:c869.</span
                  >
                </p>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >[5] MacPherson H, Tilbrook HE, Richmond SJ, Atkin K,
                    Ballard K, Bland M, et al. Alexander Technique Lessons,
                    Acupuncture Sessions or usual care for patients with chronic
                    neck pain (ATLAS): study protocol for a randomised
                    controlled trial. Trials. 2013 Jul 10;14(1):209</span
                  >
                </p>
                <p>
                  <span style="color: #000000"
                    ><span style="font-weight: 400">[6] MacPherson H </span
                    ><i><span style="font-weight: 400">et al</span></i
                    ><span style="font-weight: 400"
                      >, Alexander Technique Lessons or Acupuncture Sessions for
                      Persons With Chronic Neck Pain: A Randomized Trial, Ann
                      Intern Med. 2015;163:653-662</span
                    ></span
                  >
                </p>
                <p>
                  <span style="font-weight: 400; color: #000000"
                    >[7] Annals Editors, Discrepancies Between Prespecified and
                    Reported Outcomes, Ann Intern Med. Published online 22
                    December 2015.</span
                  >
                </p>
                <div class="social">
                  <a
                    class="synved-social-button synved-social-button-share synved-social-size-48 synved-social-resolution-normal synved-social-provider-facebook nolightbox"
                    data-provider="facebook"
                    target="_blank"
                    rel="nofollow"
                    title="Share on Facebook"
                    href="https://www.facebook.com/sharer.php?u=http%3A%2F%2Fcompare-trials.org%2Fblog%2Fpost-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making%2F&#038;t=Post-hoc%20%E2%80%9Cpre-specification%E2%80%9D%20and%20undeclared%20deferral%20of%20results%3A%20a%20broken%20record%20in%20the%20making&#038;s=100&#038;p&#091;url&#093;=http%3A%2F%2Fcompare-trials.org%2Fblog%2Fpost-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making%2F&#038;p&#091;images&#093;&#091;0&#093;=&#038;p&#091;title&#093;=Post-hoc%20%E2%80%9Cpre-specification%E2%80%9D%20and%20undeclared%20deferral%20of%20results%3A%20a%20broken%20record%20in%20the%20making"
                    style="
                      font-size: 0px;
                      width: 48px;
                      height: 48px;
                      margin: 0;
                      margin-bottom: 5px;
                      margin-right: 5px;
                    "
                    ><img
                      alt="Facebook"
                      title="Share on Facebook"
                      class="synved-share-image synved-social-image synved-social-image-share"
                      width="48"
                      height="48"
                      style="
                        display: inline;
                        width: 48px;
                        height: 48px;
                        margin: 0;
                        padding: 0;
                        border: none;
                        box-shadow: none;
                      "
                      src="../../wp-content/plugins/social-media-feather/synved-social/image/social/regular/48x48/facebook.png" /></a
                  ><a
                    class="synved-social-button synved-social-button-share synved-social-size-48 synved-social-resolution-normal synved-social-provider-twitter nolightbox"
                    data-provider="twitter"
                    target="_blank"
                    rel="nofollow"
                    title="Share on Twitter"
                    href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fcompare-trials.org%2Fblog%2Fpost-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making%2F&#038;text=COMPare%3A%20Tracking%20switched%20outcomes%20in%20clinical%20trials"
                    style="
                      font-size: 0px;
                      width: 48px;
                      height: 48px;
                      margin: 0;
                      margin-bottom: 5px;
                    "
                    ><img
                      alt="twitter"
                      title="Share on Twitter"
                      class="synved-share-image synved-social-image synved-social-image-share"
                      width="48"
                      height="48"
                      style="
                        display: inline;
                        width: 48px;
                        height: 48px;
                        margin: 0;
                        padding: 0;
                        border: none;
                        box-shadow: none;
                      "
                      src="../../wp-content/plugins/social-media-feather/synved-social/image/social/regular/48x48/twitter.png" /></a
                  ><a
                    class="synved-social-button synved-social-button-share synved-social-size-48 synved-social-resolution-hidef synved-social-provider-facebook nolightbox"
                    data-provider="facebook"
                    target="_blank"
                    rel="nofollow"
                    title="Share on Facebook"
                    href="https://www.facebook.com/sharer.php?u=http%3A%2F%2Fcompare-trials.org%2Fblog%2Fpost-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making%2F&#038;t=Post-hoc%20%E2%80%9Cpre-specification%E2%80%9D%20and%20undeclared%20deferral%20of%20results%3A%20a%20broken%20record%20in%20the%20making&#038;s=100&#038;p&#091;url&#093;=http%3A%2F%2Fcompare-trials.org%2Fblog%2Fpost-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making%2F&#038;p&#091;images&#093;&#091;0&#093;=&#038;p&#091;title&#093;=Post-hoc%20%E2%80%9Cpre-specification%E2%80%9D%20and%20undeclared%20deferral%20of%20results%3A%20a%20broken%20record%20in%20the%20making"
                    style="
                      font-size: 0px;
                      width: 48px;
                      height: 48px;
                      margin: 0;
                      margin-bottom: 5px;
                      margin-right: 5px;
                    "
                    ><img
                      alt="Facebook"
                      title="Share on Facebook"
                      class="synved-share-image synved-social-image synved-social-image-share"
                      width="48"
                      height="48"
                      style="
                        display: inline;
                        width: 48px;
                        height: 48px;
                        margin: 0;
                        padding: 0;
                        border: none;
                        box-shadow: none;
                      "
                      src="../../wp-content/plugins/social-media-feather/synved-social/image/social/regular/96x96/facebook.png" /></a
                  ><a
                    class="synved-social-button synved-social-button-share synved-social-size-48 synved-social-resolution-hidef synved-social-provider-twitter nolightbox"
                    data-provider="twitter"
                    target="_blank"
                    rel="nofollow"
                    title="Share on Twitter"
                    href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fcompare-trials.org%2Fblog%2Fpost-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making%2F&#038;text=COMPare%3A%20Tracking%20switched%20outcomes%20in%20clinical%20trials"
                    style="
                      font-size: 0px;
                      width: 48px;
                      height: 48px;
                      margin: 0;
                      margin-bottom: 5px;
                    "
                    ><img
                      alt="twitter"
                      title="Share on Twitter"
                      class="synved-share-image synved-social-image synved-social-image-share"
                      width="48"
                      height="48"
                      style="
                        display: inline;
                        width: 48px;
                        height: 48px;
                        margin: 0;
                        padding: 0;
                        border: none;
                        box-shadow: none;
                      "
                      src="../../wp-content/plugins/social-media-feather/synved-social/image/social/regular/96x96/twitter.png"
                  /></a>
                </div>
              </div>
              <footer class="entry-footer">
                <p class="entry-meta">
                  <span class="entry-tags"
                    >Tagged With:
                    <a href="../tag/annals/index.html" rel="tag"
                      >annals</a
                    ></span
                  >
                </p>
              </footer>
            </article>
            <section
              class="author-box"
              itemprop="author"
              itemscope
              itemtype="https://schema.org/Person"
            >
              <img
                alt=""
                src="https://0.gravatar.com/avatar/cb0849bd9365570b701a418bcdd79c6f?s=176&#038;d=mm&#038;r=g"
                srcset="
                  https://0.gravatar.com/avatar/cb0849bd9365570b701a418bcdd79c6f?s=352&amp;d=mm&amp;r=g 2x
                "
                class="avatar avatar-176 photo"
                height="176"
                width="176"
              />
              <h1 class="author-box-title">
                About <span itemprop="name">Henry Drysdale</span>
              </h1>
              <div class="author-box-content" itemprop="description"></div>
            </section>
            <div class="after-entry widget-area">
              <section id="search-3" class="widget widget_search">
                <div class="widget-wrap">
                  <form
                    class="search-form"
                    itemprop="potentialAction"
                    itemscope
                    itemtype="https://schema.org/SearchAction"
                    method="get"
                    action="../../index.html"
                    role="search"
                  >
                    <meta
                      itemprop="target"
                      content="https://www.compare-trials.org/?s={s}"
                    /><input
                      itemprop="query-input"
                      type="search"
                      name="s"
                      placeholder="Search this website &#x2026;"
                    /><input type="submit" value="Search" />
                  </form>
                </div>
              </section>
            </div>
            <div class="entry-comments" id="comments">
              <h3>Comments</h3>
              <ol class="comment-list">
                <li class="comment even thread-even depth-1" id="comment-351">
                  <article
                    itemprop="comment"
                    itemscope
                    itemtype="https://schema.org/Comment"
                  >
                    <header class="comment-header">
                      <p
                        class="comment-author"
                        itemprop="author"
                        itemscope
                        itemtype="https://schema.org/Person"
                      >
                        <img
                          alt=""
                          src="https://2.gravatar.com/avatar/5203a86ba7679af22fa15a3e0a0f9899?s=120&#038;d=mm&#038;r=g"
                          srcset="
                            https://2.gravatar.com/avatar/5203a86ba7679af22fa15a3e0a0f9899?s=240&amp;d=mm&amp;r=g 2x
                          "
                          class="avatar avatar-120 photo"
                          height="120"
                          width="120"
                        /><span itemprop="name">Jackie Marchington</span>
                        <span class="says">says</span>
                      </p>

                      <p class="comment-meta">
                        <time
                          class="comment-time"
                          datetime="2016-03-14T10:45:03+00:00"
                          itemprop="datePublished"
                          ><a
                            href="index.html#comment-351"
                            class="comment-time-link"
                            itemprop="url"
                            >March 14, 2016 at 10:45 am</a
                          ></time
                        >
                      </p>
                    </header>

                    <div class="comment-content" itemprop="text">
                      <p>
                        Speaking of post-hoc pre-specification, please can you
                        include the dates you revised your COMPARE protocol
                        (appendices 1 and 2) in your methodology pdf?
                        Inevitably, and as you state in the appendix, you have
                        refined your process as the project has progressed and
                        it would be interesting to see which
                        publications/responses may have driven your changes.
                        (And you really should date your protocol in the
                        document!)
                      </p>
                    </div>

                    <div class="comment-reply">
                      <a
                        rel="nofollow"
                        class="comment-reply-link"
                        href="index.html%3Freplytocom=351.html#respond"
                        onclick='return addComment.moveForm( "comment-351", "351", "respond", "268" )'
                        aria-label="Reply to Jackie Marchington"
                        >Reply</a
                      >
                    </div>
                  </article>
                </li>
                <!-- #comment-## -->
              </ol>
            </div>
            <div id="respond" class="comment-respond">
              <h3 id="reply-title" class="comment-reply-title">
                Leave a Reply
                <small
                  ><a
                    rel="nofollow"
                    id="cancel-comment-reply-link"
                    href="index.html#respond"
                    style="display: none"
                    >Cancel reply</a
                  ></small
                >
              </h3>
              <form
                action="https://www.compare-trials.org/wp-comments-post.php"
                method="post"
                id="commentform"
                class="comment-form"
                novalidate
              >
                <p class="comment-notes">
                  <span id="email-notes"
                    >Your email address will not be published.</span
                  >
                  Required fields are marked <span class="required">*</span>
                </p>
                <p class="comment-form-comment">
                  <label for="comment">Comment</label>
                  <textarea
                    id="comment"
                    name="comment"
                    cols="45"
                    rows="8"
                    maxlength="65525"
                    aria-required="true"
                    required="required"
                  ></textarea>
                </p>
                <p class="comment-form-author">
                  <label for="author"
                    >Name <span class="required">*</span></label
                  >
                  <input
                    id="author"
                    name="author"
                    type="text"
                    value=""
                    size="30"
                    maxlength="245"
                    aria-required="true"
                    required="required"
                  />
                </p>
                <p class="comment-form-email">
                  <label for="email"
                    >Email <span class="required">*</span></label
                  >
                  <input
                    id="email"
                    name="email"
                    type="email"
                    value=""
                    size="30"
                    maxlength="100"
                    aria-describedby="email-notes"
                    aria-required="true"
                    required="required"
                  />
                </p>
                <p class="comment-form-url">
                  <label for="url">Website</label>
                  <input
                    id="url"
                    name="url"
                    type="url"
                    value=""
                    size="30"
                    maxlength="200"
                  />
                </p>
                <p class="form-submit">
                  <input
                    name="submit"
                    type="submit"
                    id="submit"
                    class="submit"
                    value="Post Comment"
                  />
                  <input
                    type="hidden"
                    name="comment_post_ID"
                    value="268"
                    id="comment_post_ID"
                  />
                  <input
                    type="hidden"
                    name="comment_parent"
                    id="comment_parent"
                    value="0"
                  />
                </p>
                <p style="display: none">
                  <input
                    type="hidden"
                    id="akismet_comment_nonce"
                    name="akismet_comment_nonce"
                    value="96b51b28ae"
                  />
                </p>
                <p style="display: none">
                  <input type="hidden" id="ak_js" name="ak_js" value="47" />
                </p>
              </form>
            </div>
            <!-- #respond -->
          </main>
        </div>
      </div>
      <div class="footer-widgets">
        <div class="wrap">
          <div class="footer-widgets-1 widget-area">
            <section id="text-2" class="widget widget_text">
              <div class="widget-wrap">
                <h4 class="widget-title widgettitle">How to cite us</h4>
                <div class="textwidget">
                  <p>
                    Prior to publication of the first paper on COMPare, please
                    cite this project as:
                  </p>
                  <p>
                    <em>The COMPare Trials Project.</em> Goldacre B, Drysdale H,
                    Powell-Smith A, et al. www.COMPare-trials.org, 2016.
                  </p>
                  <p>Or alternatively:</p>
                  <p>
                    <em>The COMPare Trials Project.</em> Ben Goldacre, Henry
                    Drysdale, Anna Powell-Smith, Aaron Dale, Ioan Milosevic,
                    Eirion Slade, Philip Hartley, Cicely Marston, Kamal Mahtani,
                    Carl Heneghan. www.COMPare-trials.org, 2016.
                  </p>
                </div>
              </div>
            </section>
          </div>
        </div>
      </div>
      <footer
        class="site-footer"
        itemscope
        itemtype="https://schema.org/WPFooter"
      >
        <div class="wrap">
          <span class="logos">
            <a href="https://www.ox.ac.uk"
              ><img
                src="../../wp-content/uploads/2016/01/oxford_logo.png"
                alt="University of Oxford logo"
                height="40"
            /></a>
            <a href="https://www.phc.ox.ac.uk"
              ><img
                src="../../wp-content/uploads/2016/01/nuffield_logo.png"
                alt="Nuffield Department of Primary Care Health Sciences logo"
                height="40"
            /></a>
            <a href="https://www.cebm.net/"
              ><img
                src="../../wp-content/uploads/2016/01/cebm_logo.png"
                alt="Centre for Evidence-Based Medicine logo"
                height="40"
            /></a>
          </span>

          <p>
            Copyright &#x000A9;&nbsp;2019 &middot;
            <a href="https://www.bennett.ox.ac.uk/">Bennett Institute for Applied Data Science</a>
          </p>
        </div>
      </footer>
    </div>
    <script
      type="text/javascript"
      src="https://cdn.datatables.net/s/dt/dt-1.10.10,fh-3.1.0,r-2.0.0/datatables.min.js"
    ></script>
    <script src="../../wp-content/uploads/2016/01/tabletop.js"></script>
    <script src="../../wp-content/uploads/2016/01/countUp.js"></script>
    <script src="../../wp-content/uploads/2016/01/all.js"></script>
    <script
      type="text/javascript"
      src="../../wp-content/plugins/akismet/_inc/form.js"
    ></script>
    <script
      type="text/javascript"
      src="../../wp-content/plugins/wp-show-more/wpsm-script.js"
    ></script>
    <script
      type="text/javascript"
      src="../../wp-includes/js/comment-reply.min.js"
    ></script>
    <script
      type="text/javascript"
      src="../../wp-content/plugins/easy-twitter-feed-widget/lib/js/widget-easy-twitter-feed-widget.js"
    ></script>
    <script
      type="text/javascript"
      src="../../wp-includes/js/wp-embed.min.js"
    ></script>
  </body>
</html>
